Related Experiment Videos
Monocyte activation by tumour cells: a role for carbohydrate structures associated with CD2
1Institut für Pathologie/Tumorimmunologie, Universitätsklinikum Regensburg, Germany.
Scandinavian Journal of Immunology
|January 1, 1995
Summary
Tumor cell CD2 carbohydrate structures, particularly those with sialic acid, stimulate monocytes to release tumor necrosis factor-alpha (TNF-alpha). This suggests unique tumor cell glycosylation patterns are key in monocyte recognition of cancer cells.
Area of Science:
- Immunology
- Cell Biology
- Glycobiology
Background:
- Monocytes/macrophages are crucial for anti-tumor immunity, releasing tumor necrosis factor-alpha (TNF-alpha).
- Mechanisms of tumor cell recognition by monocytes are not fully understood.
- Previous studies suggested CD2 on Jurkat cells stimulates TNF-alpha secretion.
Purpose of the Study:
- To investigate the role of CD2 carbohydrate moieties in monocyte activation.
- To determine if tumor cell-specific CD2 glycosylation drives TNF-alpha secretion.
- To elucidate the molecular basis of monocyte recognition of tumor cells.
Main Methods:
- Comparing TNF-alpha secretion induced by CD2 from Jurkat (tumor) cells versus T cells.
- Affinity purification of CD2 and treatment with enzymes (neuraminidase, PNGaseF, pronase).
- Blocking experiments using anti-CD2 antibodies.
Main Results:
- CD2 from Jurkat cells, but not resting T cells, stimulated TNF-alpha secretion.
- Purified CD2 from Jurkat cells retained stimulatory capacity, blocked by anti-CD2 antibodies.
- Sialic acid-containing carbohydrates on CD2 were essential for monocyte activation.
Conclusions:
- Tumor cell-specific glycosylation patterns on CD2 mediate monocyte activation.
- Sialic acid-rich carbohydrate moieties on tumor cell CD2 are key for TNF-alpha secretion.
- This highlights a novel mechanism in monocyte-mediated anti-tumor responses.